Monkeypox infection and resolution after treatment with tecovirimat in two patients with HIV disease
The ongoing 2022 monkeypox virus outbreak has disproportionately impacted men who have sex with men and is associated with an increased frequency of atypical symptoms. The impetus for this outbreak is currently unknown. Experts suggest it may be related to the cessation of routine smallpox vaccinati...
Main Authors: | Norman L. Beatty, Coulter Small, Tyler Degener, Andrés F. Henao Martinez |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-11-01
|
Series: | Therapeutic Advances in Infectious Disease |
Online Access: | https://doi.org/10.1177/20499361221138349 |
Similar Items
-
Monkeypox treatment: Is tecovirimat the answer?
by: Faizan Niaz, et al.
Published: (2022-11-01) -
A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome
by: Clément Viguier, et al.
Published: (2022-12-01) -
Tecovirimat for monkeypox in Central African Republic under expanded access
by: Mbrenga, F, et al.
Published: (2022) -
Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak
by: Brittany Perzia, et al.
Published: (2023-03-01) -
Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: astudy protocol for an Expanded Access Programme
by: Bourner, J, et al.
Published: (2024)